Market Data
Markets

Stock Market Today: Nasdaq Cuts Losses As Dow Still Falls Nearly 800 Points; Eli Lilly Hits Sell Signal (Live Coverage)

By Mark GrundellYahoo FinanceMarch 5, 2026 at 9:23 PMBearish1 min read

Tech Resilience Offsets Broader Market Weakness Amid Inflation Concerns

The Nasdaq's ability to pare losses while the Dow plummeted nearly 800 points highlights a divergence in market performance. This suggests sectors like technology may be demonstrating greater resilience or attracting specific investment flows even amidst broader economic anxieties.

Analyst sentiment: Bearish
What to watch next

Investors should scrutinize upcoming inflation reports and Federal Reserve statements for signs of shifting monetary policy.

Key Takeaways

  • 1Nasdaq partially recovered losses.
  • 2Dow Jones Industrial Average fell significantly (-800 points).
  • 3Eli Lilly (LLY) received a 'sell signal'.

The stock market saw divergent performance today, with the Nasdaq paring losses while the Dow Jones Industrial Average plunged nearly 800 points, signaling broad market weakness. This divergence suggests a potential rotation or sector-specific pressures. Investors should monitor inflation data and Federal Reserve commentary for insights into future market direction, particularly for growth stocks versus broader market indices. Eli Lilly's 'sell signal' indicates concerns within the pharmaceutical sector or company-specific pressures.

The stock market concluded a session marked by divergence, with the technology-heavy Nasdaq Composite significantly paring earlier losses, effectively cutting its decline to below 1%. In stark contrast, the Dow Jones Industrial Average experienced a substantial drop, closing down nearly 800 points, reflecting broad-based market weakness across more traditional industrial and financial sectors. This performance differential suggests that while overall market sentiment remains bearish, investment capital may be finding relative safe havens or growth opportunities within specific technology and innovation-driven companies. This market split indicates investors are grappling with contrasting narratives. On one hand, persistent inflation concerns and the anticipation of aggressive monetary tightening by the Federal Reserve are weighing heavily on the broader economy, particularly impacting value and cyclical stocks. On the other hand, the underlying strength and future potential of certain tech firms might be viewed as attractive despite rising interest rates. The market also saw Eli Lilly hit a 'sell signal,' indicating company-specific or sector-wide pressures within pharmaceuticals, potentially driven by valuation concerns or pipeline expectations. Moving forward, market participants will be closely monitoring new inflation data, particularly the Consumer Price Index (CPI) report, and any subsequent commentary from Federal Reserve officials. These economic indicators and policy signals will be crucial in determining whether the current market divergence persists or if a more uniform trend, either upward or downward, will emerge across major indices in the coming weeks.

Related Articles

You May Also Like